CFAP20: Cilia and Flagella Associated Protein Plays A Role in Air Cleaning and Disease Development

Target Name: CFAP20

NCBI ID: G29105

CFAP20

CFAP20: Cilia and Flagella Associated Protein Plays A Role in Air Cleaning and Disease Development

CFAP20 (Cilia- and flagella-associated protein 20) is a protein that is expressed in the cilia and flagella, which are the two structures that line the surface of the human body. The cilia are small, hair-like structures that are responsible for filtering out bacteria and other pathogens that may be present in the air we breathe. The flagella are long, thread-like structures that are responsible for propelling the cilia and allowing them to move and clean the air that we breathe out of our nostrils. CFAP20 is a protein that is associated with the cilia and flagella and has been shown to play a role in the regulation of the movement of these structures.

One of the main functions of CFAP20 is to help keep the cilia and flagella in their correct position and functioning properly. This is important because if the cilia or flagella are not properly aligned or functioning, it can lead to a variety of different health problems, including respiratory infections, allergies, and even some forms of cancer. CFAP20 helps to ensure that this alignment and function are maintained, which helps to keep the body healthy.

CFAP20 is also involved in the regulation of the strength and movement of the cilia and flagella. This is important because the cilia and flagella are constantly moving and changing position in order to filter out the air that we breathe and keep the body properly ventilated. CFAP20 helps to regulate the strength and movement of these structures in order to ensure that they are able to do their job effectively.

In addition to its role in the regulation of the cilia and flagella, CFAP20 has also been shown to play a role in the development and progression of various diseases. For example, studies have shown that individuals with certain genetic mutations, such as those that result in the loss of cilia or flagella, may be more likely to develop respiratory infections or other diseases. CFAP20 may also be a drug target or biomarker in these cases, as researchers may be interested in using it to develop new treatments for these diseases.

CFAP20 is also of interest in the context of cancer, as it has been shown to play a role in the development and progression of many types of cancer. For example, studies have shown that individuals with certain genetic mutations, such as those that result in the loss of cilia or flagella, may be more likely to develop certain forms of cancer. CFAP20 may also be a drug target or biomarker in these cases, as researchers may be interested in using it to develop new treatments for these cancers.

CFAP20 is a protein that is expressed in the cilia and flagella and has been shown to play a role in the regulation of these structures. It is also involved in the regulation of the strength and movement of these structures, as well as the development and progression of various diseases, including cancer. As a result, CFAP20 may be of interest as a drug target or biomarker for the treatment of these diseases. Further research is needed to fully understand its role and potential in these areas.

Protein Name: Cilia And Flagella Associated Protein 20

Functions: Cilium- and flagellum-specific protein that plays a role in axonemal structure organization and motility. Involved in the regulation of the size and morphology of cilia (PubMed:24414207). Required for axonemal microtubules polyglutamylation (PubMed:24414207)

The "CFAP20 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CFAP20 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets